Activated dendritic cells (DCs) play a key role in the immunological response through the presentation or cross-presentation of tumor antigens to the CD4+ and CD8+ T cells, which is essential for the maturation and activation of tumor-specific cytotoxic T lymphocytes that move to the tumor’s niche to eliminate tumor cells. The gene discussed is CD8A; the disease is neoplasm.